Clinical Trial Update: A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 study comparing infusion rates of tocilizumab in adults with moderate to severe rheumatoid arthritis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-10-22